Texas A&M University

Company

Related News

Grail's Galleri Blood Test Fails to Reduce Late-Stage Cancers in Major Trial

A major clinical trial found that Grail's Galleri blood test did not reduce late-stage cancer diagnoses, raising questions about multi-cancer early detection. Meanwhile, the FDA approved a second blood-based colorectal cancer screening test, and an AI-powered liquid biopsy showed promise for Ewing sarcoma.

Related Clinical Trials

NCT ID Title Status Phase
NCT07780188

Lean Beef as Part of a Healthy Meal Plan in Adolescents With Polycystic Ovary Syndrome (PCOS)/Polyendocrine Metabolic Ovarian Syndrome (PMOS)

RECRUITING NA
NCT07766252

CCHW-delivered CFH-based Cancer Prevention Program Among Chinese Americans

COMPLETED NA
NCT07761052

The Latino Youth and Family Empowerment Study - III (LYFE-III): Bringing to Scale a Culturally-Adapted and Evidence-Based Intervention for Latino Families

NOT_YET_RECRUITING NA
NCT07732569

Live Long, Heart Strong: A Digital Nutrition Intervention for Emerging Adults

NOT_YET_RECRUITING NA
NCT07686159

Evaluation of Mosquito Repellent Products' Efficacy, Safety, and Public Health Implications

COMPLETED NA
NCT07659821

Harvesting Health: Advancing Nutrition and Wellness for Moms and Babies

RECRUITING NA
NCT07648758

Produce Prescription for Healthy Blood Pressure

COMPLETED NA
NCT07631546

Investigating Behavior Change Methods for the Management of Hypertension

ACTIVE_NOT_RECRUITING NA
NCT07478250

First Responder Safety Training (FiRST)

NOT_YET_RECRUITING NA
NCT07329452

Menu to Meal (M2M) Menu Labeling Intervention Study

COMPLETED NA